Less than 1% of positive specimens in the U.S. are being sequenced to determine whether they have worrisome mutations. Other countries do better and can more quickly see threats coming at them.
from Section Page News - Modern Healthcare https://ift.tt/3oMpY9t
via IFTTT
No comments:
Post a Comment